Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Capricor Therapeutics Inc., 3 years.
Capricor Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Capricor Therapeutics Inc. June 4, 202679.3%
-
Capricor Therapeutics Inc. May 22, 202559.7%
-
Capricor Therapeutics Inc. May 14, 202475.1%
-
Capricor Therapeutics Inc. June 12, 202384.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 2, 2026 | Capricor Therapeutics Inc. | Option exercise | +7,529 | $3.18 | $23,942 |
| Apr 2, 2026 | Capricor Therapeutics Inc. | Open-market sale | −7,529 | $32.00 | $240,928 |
| Apr 1, 2026 | Capricor Therapeutics Inc. | Option exercise | +53,735 | $4.86 | $261,152 |
| Apr 1, 2026 | Capricor Therapeutics Inc. | Open-market sale | −53,735 | $31.03 | $1,667,397 |
| Mar 31, 2026 | Capricor Therapeutics Inc. | Option exercise | +61,265 | $4.86 | $297,748 |
| Mar 31, 2026 | Capricor Therapeutics Inc. | Open-market sale | −61,265 | $30.17 | $1,848,365 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.